Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease by Ansari A, Arenas M, Greenfield S M, Morris D, Lindsay J, Gilshenan K, Smith M, Lewis C, Marinaki A, Duley J, Sanderson J in Alimentary pharmacology & therapeutics (2008). PubMed

Abstract

To investigate whether pharmacogenetic loci or metabolite concentrations explain clinical response or side effects to AZA.

[ hide abstract ]

Discussed In Paper

Related In Paper

Variant Annotations

Sign in to see variant annotations.